| Certificates/Standards: | N; |
| Monthly Output: | Not provided |
| Regional: | Not provided |
| Packaging Information: | Not provided |
| Mode Of Payment: | Not provided |
| Delivery Lead Time: | Not provided |
| Main Sales Markets: | North America，Central/South America，Western Europe，Eastern Europe，Australasia，Asia，Middle East，Africa |
| Sample Provided: | No |
| Sample Policy: | Not provided |
| Minimum Quantity: | Not provided |
To meet growing demand for more effective, low-dose solutions in the joint health market, Bioiberica has developed Collavant n2 - a widely researched, natural-origin ingredient that supplies native type II collagen to support joint health. Extracted from chicken sternum, the manufacture of Collavant n2 is strictly controlled to maintain its characteristic triple helix structure and the biologically active epitopes of the native protein. A low dose of only 40 mg/day of Collavant n2 is required to be effective, meeting consumer demand for convenient, low-dose products and reducing pill fatigue.
沪公网安备31010402001403号
